|Articles|October 23, 2012

Global Launch in the IMS Health Era

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Pharmaceutical Executive Daily: China's Latest Policy Guidance

ByNicholas Jacobus

June 11th 2026

Accelerating Speed to Patient: A Conversation With Eli Lilly’s Sarah O’Keeffe

ByMichael Christel

June 11th 2026

Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ

ByNicholas Jacobus

June 11th 2026

China Pharma Trends: Premium Pricing and Priority Access for True Innovations

ByBruce Liu

June 11th 2026

How Basket-Trials are Reshaping Drug Development Timelines

ByMike Hollan,Lisa Bollinger

June 11th 2026

Global Launch in the IMS Health Era

Related Content

Pharmaceutical Executive Daily: China's Latest Policy Guidance

Accelerating Speed to Patient: A Conversation With Eli Lilly’s Sarah O’Keeffe

Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ

China Pharma Trends: Premium Pricing and Priority Access for True Innovations

How Basket-Trials are Reshaping Drug Development Timelines

Trending on PharmExec

Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO

How Basket-Trials are Reshaping Drug Development Timelines

The New Capital of Care in Rare Disease

Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ

Parabilis Medicines Raises $670 Million in Initial Public Offering